sars-cov-2

Documents about sars-cov-2

• On Immunological Imprinting#263688ScholarlyCommons at Penn
• Cobalt(III)–Schiff Base Coordination to Nsp1, a SARS-CoV-2 protein#272112CaltechDATA
• Cobalt(III)–Schiff Base Coordination to Nsp1, a SARS-CoV-2 protein#272113CaltechDATA
• Cobalt(III)–Schiff Base Coordination to Nsp1, a SARS-CoV-2 protein#272114CaltechDATA
• Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings#312069HAL (France)
• Characteristics of SARS-CoV-2 Reinfection#825284ClinicalTrials.gov
• Behavior, Environment And Treatments for Covid-19#830821ClinicalTrials.gov
• COVID-19 Biorepository#831356ClinicalTrials.gov
• Prognostic Factors of Patients With COVID-19#835431ClinicalTrials.gov
• Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.#180259ClinicalTrials.gov
• Factors associated with disease severity amongst children admitted with SARS-COV-2 infection in Gauteng and KwaZulu-Natal, 2020 to 2022#447680WIReDSpace
• Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis#481125OpenAlex
• Assessment of Long-term Sequelae of Coronavirus Disease 2019 (COVID-19) Pneumonia With Chest CT and Pulmonary Function Tests#160195ClinicalTrials.gov
• Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease#303634ClinicalTrials.gov
• Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial.#448435Dipòsit Digital de la Universitat de Barcelona
• Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19#828038ClinicalTrials.gov
• The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001#874280ClinicalTrials.gov
• The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)#876186ClinicalTrials.gov
• Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults#861752ClinicalTrials.gov
• Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines#125907ClinicalTrials.gov
• COVID-19-Hospitalisierungen in Deutschland#11934DataCite
• COVID-19-Hospitalisierungen in Deutschland#13348DataCite
• COVID-19-Hospitalisierungen in Deutschland#14622DataCite
• COVID-19-Hospitalisierungen in Deutschland#20803DataCite
• COVID-19-Hospitalisierungen in Deutschland#120836DataCite
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults#123533ClinicalTrials.gov
• Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny#262018HAL (France)
• Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission#464554LSHTM Data Compass
• The Ethics of Deliberate Exposure to SARS-CoV-2 to Induce Immunity#771441PhilArchive
• Nonenzymatic Detection of SARS-CoV‑2 RNA Using DNA Nanoswitches.#785750NCBI PubMed Central
• Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19#803426ClinicalTrials.gov
• Investigation the Effect of Montelukast in COVID-19#831436ClinicalTrials.gov
• Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus#875412ClinicalTrials.gov
• A rapid, easy, and scalable whole blood monocyte CD169 assay for outpatient screening during SARS-CoV-2 outbreak, and potentially other emerging disease outbreaks#205731HAL (France)
• Compliance with Hand Sanitizer Quality during the SARS-CoV-2 Pandemic: Assessing the Impurities in an Ethanol Plant#463989DigitalCommons@University of Nebraska
• An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines.#623549ClinicalTrials.gov
• Omicron SARS-CoV-2 epidemic in England during February 2022: a series of cross-sectional community surveys#466371Spiral
• Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting#803243ClinicalTrials.gov
• The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients#185593IRIS
• Pathogen spectrum and epidemiology of respiratory tract infections in Quzhou, Eastern China, from November 2023 to July 2024: A post‑COVID‑19 surveillance study#269666PLOS
• Modelos Bayesianos espaciotemporales para evaluar factores asociados en la incidencia de COVID-19 en Colombia#434691Repositorio Institucional Javeriano
• Análise da soroprevalência e eficácia da vacina contra COVID-19 em cirurgiões bucomaxilofaciais e auxiliares de saúde bucal pós pandemia em um estado brasileiro#469647Repositório Institucional da Universidade Federal de Sergipe
• Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland#417589ClinicalTrials.gov
• Inhibitor Binding Influences the Protonation States of Histidines in SARS-CoV-2 Main Protease#288252HAL (France)
• CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2))#363556ClinicalTrials.gov
• The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution#661963HAL (France)
• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)#875700ClinicalTrials.gov
• Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)#859205ClinicalTrials.gov
• Noninvasive SARS-CoV-2 detection using a low-cost electronic nose.#3946NCBI PubMed Central
• COVID-ARE-Konsultationsinzidenz#14610DataCite